BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/25/2025 10:06:20 AM | Browse: 141 | Download: 557
Publication Name World Journal of Psychiatry
Manuscript ID 102852
Country United States
ISSN 2220-3206 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Psychiatry
Manuscript Type Letter to the Editor
Article Title Optimizing chemotherapy outcomes: The role of mindfulness in Epirubicin treatment for urinary tumors
Manuscript Source Invited Manuscript
All Author List Pouria Abolfazli, Cristina Nkene Apue Nchama and Brandon Lucke-Wold
ORCID
Author(s) ORCID Number
Pouria Abolfazli http://orcid.org/0000-0001-7390-2812
Brandon Lucke-Wold http://orcid.org/0000-0001-6577-4080
Funding Agency and Grant Number
Corresponding Author Brandon Lucke-Wold, MD, PhD, Lillian S. Wells Department of Neurosurgery, University of Florida, 1505 SW Archer Road, Gainesville, FL 32608, United States. brandon.lucke-wold@neurosurgery.ufl.edu
Key Words Urinary system tumors; Mindfulness-based intervention; Epirubicin; Bladder cancer; Cancer care
Core Tip Urinary system tumors often cause varying degrees of negative psychological symptoms, such as depression and dysphoria. These psychological factors significantly impact patients’ immune function and indirectly affect the intervention and prognosis of patients with cancer. Epirubicin (EPI) can improve the prognosis of patients with urinary system tumors, but it also has certain side effects. Mindfulness interventions are beneficial for enhancing psychological adaptability in cancer patients. In this study, the combination of EPI and mindfulness intervention achieved remarkable clinical results in patients with depression-complicated urinary system tumors.
Publish Date 2025-03-25 10:06
Citation

Abolfazli P, Apue Nchama CN, Lucke-Wold B. Optimizing chemotherapy outcomes: The role of mindfulness in Epirubicin treatment for urinary tumors. World J Psychiatry 2025; 15(4): 102852

URL https://www.wjgnet.com/2220-3206/full/v15/i4/102852.htm
DOI https://dx.doi.org/10.5498/wjp.v15.i4.102852
Full Article (PDF) WJP-15-102852-with-cover.pdf